Neoplasm
Not recruitingStudy on the Safety of Tiragolumab and Atezolizumab for Patients with Advanced or Metastatic Solid Tumors
- Disease:Neoplasm
- Substances:–
Greece- Participants:18–64 years · 65+ years
- Sponsor:F. Hoffmann-La Roche AG
Rare diseases
Investigational molecules
Locations
Back to Greece16 clinical trials in Filothei, Greece. Every trial is listed in the EU Clinical Trials Register and updated daily.
Greece
Greece
Greece
GreeceThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on platinum-sensitive ovarian cancer and advanced breast cancer treatments, evaluating new combination therapies and maintenance approaches.
Multiple studies examining targeted therapies and novel drug combinations to improve patient outcomes.
Research initiatives targeting rare neurological conditions, including studies on Lennox-Gastaut syndrome and innovative treatments for seizure management.
Focused on developing new therapeutic approaches for complex neurological conditions.
Specialized research programs investigating treatments for Duchenne muscular dystrophy, exploring novel therapeutic approaches and dosing strategies.
Evaluating innovative treatments to address unmet medical needs in rare disease populations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.